Principal Controversies in Vaccine Safety in the United States
- PMID: 30753348
- DOI: 10.1093/cid/ciz135
Principal Controversies in Vaccine Safety in the United States
Abstract
Concerns about vaccine safety can lead to decreased acceptance of vaccines and resurgence of vaccine-preventable diseases. We summarize the key evidence on some of the main current vaccine safety controversies in the United States, including (1) measles, mumps, and rubella vaccine and autism; (2) thimerosal, a mercury-based vaccine preservative and the risk of neurodevelopmental disorders; (3) vaccine-induced Guillain-Barré syndrome (GBS); (4) vaccine-induced autoimmune diseases; (5) safety of human papillomavirus vaccine; (6) aluminum adjuvant-induced autoimmune diseases and other disorders; and (7) too many vaccines given early in life predisposing children to health and developmental problems. A possible small increased risk of GBS following influenza vaccination has been identified, but the magnitude of the increase is less than the risk of GBS following influenza infection. Otherwise, the biological and epidemiologic evidence does not support any of the reviewed vaccine safety concerns.
Keywords: MMR vaccine; aluminum; autism; autoimmunity; thimerosal.
Published by Oxford University Press for the Infectious Diseases Society of America 2019.
Similar articles
-
Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations.Pediatrics. 2006 Jul;118(1):e139-50. doi: 10.1542/peds.2005-2993. Pediatrics. 2006. PMID: 16818529
-
Vaccination and autoimmunity-'vaccinosis': a dangerous liaison?J Autoimmun. 2000 Feb;14(1):1-10. doi: 10.1006/jaut.1999.0346. J Autoimmun. 2000. PMID: 10648110 Review.
-
A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism.Med Sci Monit. 2004 Mar;10(3):PI33-9. Epub 2004 Mar 1. Med Sci Monit. 2004. PMID: 14976450
-
Measles-mumps-rubella vaccine and autistic spectrum disorder: report from the New Challenges in Childhood Immunizations Conference convened in Oak Brook, Illinois, June 12-13, 2000.Pediatrics. 2001 May;107(5):E84. doi: 10.1542/peds.107.5.e84. Pediatrics. 2001. PMID: 11331734 Review.
-
Vaccine-preventable diseases, vaccines and Guillain-Barre' syndrome.Vaccine. 2019 Sep 3;37(37):5544-5550. doi: 10.1016/j.vaccine.2018.05.119. Epub 2018 Jun 4. Vaccine. 2019. PMID: 29880241 Review.
Cited by
-
"They're trying to bribe you and taking away your freedoms": COVID-19 vaccine hesitancy in communities with traditionally low vaccination rates.Vaccine. 2022 Nov 28;40(50):7280-7287. doi: 10.1016/j.vaccine.2022.10.058. Epub 2022 Oct 31. Vaccine. 2022. PMID: 36334965 Free PMC article.
-
Antigenic Variability a Potential Factor in Assessing Relationship Between Guillain Barré Syndrome and Influenza Vaccine - Up to Date Literature Review.Cureus. 2020 Sep 2;12(9):e10208. doi: 10.7759/cureus.10208. Cureus. 2020. PMID: 33033684 Free PMC article. Review.
-
Risk of Guillain-Barré syndrome after vaccination against human papillomavirus: a systematic review and meta-analysis, 1 January 2000 to 4 April 2020.Euro Surveill. 2022 Jan;27(4):2001619. doi: 10.2807/1560-7917.ES.2022.27.4.2001619. Euro Surveill. 2022. PMID: 35086611 Free PMC article.
-
Biodegradable Polymers for Application as Robust Immunomodulatory Biomaterial Carrier Systems.Small. 2025 Feb 16:e2409422. doi: 10.1002/smll.202409422. Online ahead of print. Small. 2025. PMID: 39955753 Review.
-
A comprehensive insight into current control of COVID-19: Immunogenicity, vaccination, and treatment.Biomed Pharmacother. 2022 Sep;153:113499. doi: 10.1016/j.biopha.2022.113499. Epub 2022 Aug 2. Biomed Pharmacother. 2022. PMID: 36076589 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical